slides · global inventory
Plan Implementation
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 6,044
Current window 3,811-3,840
Pages 202
Rows per page 30
Slide function
3,811-3,840 of 6,044
09
The slide uses a grid-based layout to organize clinical trials by stage and therapeutic focus.Legend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Satisfaction1 hit
13
Legend Biotech | Results Presentation Deck | 15 slidesLegend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Action1 hit
11
The slide uses a three-column layout to represent the pillars of the business strategy.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
14
The slide uses a funnel-like flow from EBITDA/FCF into a three-pillar strategy.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations 1 hit
15
The slide outlines a clear M&A strategy distinguishing between tuck-in acquisitions and new market entry.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations 1 hit
16
The slide uses a checklist format for criteria and a list of strategic pillars for post-acquisition integration.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations 1 hit
04
The framework is named 'GEAR forward'.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations 1 hit
35
LKQ | Results Presentation Deck | 62 slidesLKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
05
The slide uses a Gantt-style layout to represent drug development stages.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
23
The slide outlines a multi-stage clinical trial design (Part A/B to Part C) involving immune activation with various checkpoint inhibitors.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
31
The slide outlines a clinical trial process flow from initial baskets through immune activation to a pivotal phase.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
38
The slide uses a growth curve background to imply value accumulation over time.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
14
Mainz Biomed NV | Investor Presentation Deck | 28 slidesMainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
21
The slide uses a horizontal timeline format to map product milestones against calendar years.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
22
Includes a mention of a potential combo test with ColoAlert and a research grant from the German Federal Ministry for Education and Research.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
25
The slide uses a DNA double-helix motif to represent the company's focus on molecular diagnostics.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
17
Matinas BioPharma | Investor Presentation Deck | 31 slidesMatinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
18
The slide uses a process flow diagram to illustrate the clinical trial methodology.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
27
Uses a chevron-based process flow to represent maturity stages.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Why Now1 hit
28
The slide uses a grid-based timeline layout to track multiple workstreams simultaneously.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Why Now1 hit
13
The slide uses a wave-based visual metaphor to represent sequential growth phases.MaxCyte | Results Presentation Deck | 25 slides · MaxCyte
Conference presentation Investor relations 1 hit
06
The chart uses a horizontal bar format to represent progress through clinical phases (Pre-clinical to Phase 3).MindMed | Results Presentation Deck | 20 slides · MindMed
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
19
MindMed | Results Presentation Deck | 20 slidesMindMed | Results Presentation Deck | 20 slides · MindMed
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
04
Uses a three-stage horizontal arrow process diagram to represent business evolution.ModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations Beat · Problem1 hit
11
The slide uses a matrix structure to map initiatives against impact, metrics, and financial outcomes.ModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
09
The slide uses rocket icons as markers on a timeline against a background of Earth from space.Momentus | Results Presentation Deck | 17 slides · Momentus
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
27
Nemaura Medical | Investor Presentation Deck | 29 slidesNemaura Medical | Investor Presentation Deck | 29 slides · Nemaura Medical
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
06
The slide uses a Gantt-style layout to map activities over fiscal years 2023-2026.NextNav | Investor Presentation Deck | 10 slides · NextNav
Pitch deck Investor relations Beat · ComplicationLoop · Why Now1 hit
15
The slide uses a side-by-side comparison layout to distinguish between the dose escalation (Phase 1) and the registrational intent (Phase 2) study designs.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
50
The slide uses a Gantt-chart style visualization to show the progress of three specific drug candidates (NVL-520, NVL-655, NVL-330) through clinical development phases.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations 1 hit